Related Experiment Videos
Isolated peripheral lymph node recurrence of endometrial carcinoma
R L Foote1, M F Schray, T O Wilson
1Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota 55905.
Cancer
|June 15, 1988
Summary
Isolated lymph node recurrence of endometrial cancer is uncommon but manageable. Aggressive local treatment, including surgery and radiation, can lead to long-term survival for some patients.
Area of Science:
- Oncology
- Gynecologic Oncology
- Cancer Research
Background:
- The natural history of isolated endometrial carcinoma recurrence in peripheral lymph nodes (inguinal, axillary, supraclavicular) is not well-documented.
- This specific recurrence pattern is associated with higher initial surgical stage and tumor grade.
Purpose of the Study:
- To investigate the clinical characteristics, treatment outcomes, and prognostic factors of endometrial carcinoma recurring initially in isolated peripheral lymph nodes.
- To evaluate the effectiveness of aggressive local treatment strategies for these recurrences.
Main Methods:
- Retrospective review of 22 patients with isolated inguinal, axillary, or supraclavicular lymph node recurrence of endometrial carcinoma treated between 1963 and 1986.
- Analysis of treatment modalities including surgery, radiation, and systemic therapy, alongside patient outcomes and survival data.
Main Results:
- Supraclavicular and inguinal recurrences were equally frequent; axillary recurrences were rare.
- Local control was achieved in 15 out of 22 patients, with all seven treated by excision and aggressive local irradiation achieving control.
- Significant local morbidity occurred in four patients with uncontrolled local disease.
- Supraclavicular recurrence correlated with subsequent systemic progression, while inguinal recurrence suggested subsequent abdominal progression.
- Median survival after recurrence was 19 months, but six patients achieved long-term disease-free survival (median follow-up 27 months).
Conclusions:
- Isolated peripheral lymph node recurrence of endometrial carcinoma, though associated with advanced initial disease, can be locally controlled with aggressive treatment.
- Effective systemic adjuvant therapy is needed, but thorough restaging and aggressive local management can offer potential for long-term, disease-free survival.